Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on June 30, 2011, regarding events occurring on June 29, 2011. The filing addresses corporate governance changes, specifically the election of a new director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Robert L. Dixon, Jr. to the Board of Directors, effective June 29, 2011. His term is set to expire at the 2014 annual meeting of shareholders. Additionally, Mr. Dixon was appointed to the Audit and Governance Committees.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. It states there are no arrangements or understandings between Mr. Dixon and other persons regarding his election, nor are there relationships requiring disclosure under Item 404(a) of Regulation S-K. Mr. Dixon will participate in the standard director compensation program.
Investor Verification Checklist
- Verify the effective date of Robert L. Dixon, Jr.'s board appointment (June 29, 2011).
- Confirm his committee assignments (Audit and Governance Committees).
- Review the attached press release (Exhibit 99.1) for additional biographical details on the new director.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.